Cite
Zhu Q, Cai MY, Chen CL, et al. Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes. Oncoimmunology. 2017;6(5):e1312240doi: 10.1080/2162402X.2017.1312240.
Zhu, Q., Cai, M. Y., Chen, C. L., Hu, H., Lin, H. X., Li, M., Weng, D. S., Zhao, J. J., Guo, L., & Xia, J. C. (2017). Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes. Oncoimmunology, 6(5), e1312240. https://doi.org/10.1080/2162402X.2017.1312240
Zhu, Qian, et al. "Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes." Oncoimmunology vol. 6,5 (2017): e1312240. doi: https://doi.org/10.1080/2162402X.2017.1312240
Zhu Q, Cai MY, Chen CL, Hu H, Lin HX, Li M, Weng DS, Zhao JJ, Guo L, Xia JC. Tumor cells PD-L1 expression as a favorable prognosis factor in nasopharyngeal carcinoma patients with pre-existing intratumor-infiltrating lymphocytes. Oncoimmunology. 2017 Apr 27;6(5):e1312240. doi: 10.1080/2162402X.2017.1312240. eCollection 2017. PMID: 28638740; PMCID: PMC5467992.
Copy
Download .nbib